Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Expert Insight
Spotlight Article

Decentralized manufacture of cell therapies: the challenge of operational modeling

Decentralized Manufacture

Nicholas Medcalf

Cell therapies may often benefit from a decentralized manufacturing approach. In order to choose from amongst the possible options and to coordinate the activity of the various agents in the chain of value the industry needs reliable decision-making tools. Three tools are offered here that will help with evaluation of this route. Tools for enterprise modeling, inclusive cost analysis and timing of research investment are introduced, showing the potential for applying systems engineering to decentralized manufacturing. The case is made for initiatives to encourage communities of practice and data-sharing for operational models and unit operations.

DOI: 10.18609/cgti.2019.121
Submitted for review: July 16, 2019
Citation: Cell & Gene Therapy Insights 2019; 5(10), 1133-1149.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog